United Services Automobile Association’s Karyopharm Therapeutics KPTI Stock Holding History

United Services Automobile Association’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,259	Closed	-$652K	–	1122
2019 Q2	$652K	Buy	7,259 +62	+0.9%	+$4.98K	﹤0.01%	1493
2019 Q1	$630K	Hold	7,197	–	–	﹤0.01%	1520
2018 Q4	$1.01M	Sell	7,197 -360	-5%	-$60.7K	﹤0.01%	1253
2018 Q3	$1.93M	Hold	7,557	–	–	﹤0.01%	1140
2018 Q2	$1.93M	Buy	7,557 +1,799	+31%	+$445K	0.01%	1152
2018 Q1	$1.16M	Buy	5,758 +313	+6%	+$62.4K	﹤0.01%	1308
2017 Q4	$784K	Buy	5,445 +175	+3%	+$28.1K	﹤0.01%	1285
2017 Q3	$868K	Buy	5,270 +130	+3%	+$18.6K	﹤0.01%	1223
2017 Q2	$698K	Buy	5,140 +228	+5%	+$33.7K	﹤0.01%	1242
2017 Q1	$946K	Sell	4,912 -148	-3%	-$23.8K	﹤0.01%	1099
2016 Q4	$713K	Buy	+5,060	New	+$684K	﹤0.01%	1152

Other funds holding KPTI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

United Services Automobile Association's KPTI Position: Q3 2019 in Review

United Services Automobile Association sold out of Karyopharm Therapeutics (KPTI) in Q3 2019, closing a stake of 7,259 shares — an estimated $652K sold.

United Services Automobile Association first reported a position in KPTI in Q4 2016 and held it in 11 quarters. The position peaked at $1.93M in Q3 2018. 106 funds tracked by Wall St. Rank hold KPTI as of Q3 2019.

United Services Automobile Association reported no remaining Karyopharm Therapeutics position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 7,259 Karyopharm Therapeutics shares in Q3 2019, an estimated $652K.
United Services Automobile Association first reported a position in Karyopharm Therapeutics in Q4 2016 and held it in 11 quarters.
United Services Automobile Association's Karyopharm Therapeutics position peaked at $1.93M in Q3 2018.
106 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.